Verapamil
(vuhr-AP-uh-mil)
Definition | Special instructions | Missed dose | Side effects | Warning signs | Contact us
What is verapamil?
Verapamil (Calan", Isoptin", Verelan") is in a class of drugs known as calcium channel blockers. It is used to treat high blood pressure, fast heart beats and to prevent migraine headaches. It comes as a tablet, capsule, oral liquid, or injection.
Back to top
Special Instructions
- Give this medicine only as told by the doctor and do not stop unless told to stop by your child's doctor.
- Non-sustained release tablets can be taken with or without food. Take liquid or tablets with food if it causes an upset stomach.
- Swallow long-acting products whole with food. Do not chew, break or crush. Sustained release capsules may be opened and sprinkled on soft food prior to taking.
- Shake the liquid well before each dose.
- Avoid grapefruit juice while taking this medication. Grapefruit juice could increase the amount of verapamil in your blood.
- Ask the doctor or pharmacist before giving any other drugs, over-the-counter (OTC) medicines, or herbal medications.
- Do not use after the expiration date on the bottle.
- If too much medicine is taken by accident, call the Drug and Poison Information Center (DPIC), 513-636-5111 or 1-800-222-1222, or call your child's doctor right away.
- Keep this medication out of the reach of children.
Back to top
If a Dose is Missed
For any medication information related to your child's dosing schedule and/or missed doses, contact the healthcare provider who prescribed the medication.
Back to top
Side Effects
Call your child's doctor if the following effects continue or are bothersome:
- Feeling dizzy
- Feeling tired
- Constipation
- Stomach upset
Back to top
Warning Signs
Call your child's doctor immediately if your child has:
- Severe dizziness or passes out
- Severe headache
- Chest pains
- Any rash
Back to top
Contact us
For additional information on this or any Health Topic, please call the Family Resource Center, 513-636-7606, or your pediatrician.
Back to top
Patient Education Program V 5157 1/00
Rev. 10/05, 8/07
